These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8749727)

  • 21. The effectiveness of treatment for substance abuse. Reasons for optimism.
    Miller WR
    J Subst Abuse Treat; 1992; 9(2):93-102. PubMed ID: 1512807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of managed care on access to mental health services among Medicaid enrollees receiving substance treatment.
    Bigelow DA; McFarland BH; McCamant LE; Deck DD; Gabriel RM
    Psychiatr Serv; 2004 Jul; 55(7):775-9. PubMed ID: 15232016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Processes and outcomes of substance abuse treatment between two programs for clients insured under managed care.
    McNeese-Smith D; Nyamathi A; Longshore D; Wickman M; Robertson S; Obert J; McCann M; Wells K; Wenzel SL
    Am J Drug Alcohol Abuse; 2007; 33(3):439-46. PubMed ID: 17613971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Linkage with primary medical care in a prospective cohort of adults with addictions in inpatient detoxification: room for improvement.
    Saitz R; Larson MJ; Horton NJ; Winter M; Samet JH
    Health Serv Res; 2004 Jun; 39(3):587-606. PubMed ID: 15149480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Envelopments: immersion in and emergence from drug misuse.
    Weegmann M; Khantzian EJ
    Am J Psychother; 2011; 65(2):163-77. PubMed ID: 21847893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Are we there yet? The four-year impact of a VA fellowship program on the recovery orientation of rehabilitation programs.
    Kymalainen JA; Henze KT; Deluca M; Mitton TA; Walton HM; Duffy P; Kapungu C; Lefebvre T; Alexander WH; Pinsky J
    Psychiatr Rehabil J; 2010; 33(4):320-7. PubMed ID: 20374990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Client matching: a severity-treatment intensity paradigm.
    De Leon G; Melnick G; Cleland CM
    J Addict Dis; 2008; 27(3):99-113. PubMed ID: 18956532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quality chemical dependency treatment in an era of cost containment: clinical guidelines for practitioners.
    Pacione T; Jaskula D
    Health Soc Work; 1994 Feb; 19(1):55-62. PubMed ID: 8168780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Substance abuse treatment, what do we know? An economist's perspective.
    Machado MP
    Eur J Health Econ; 2005 Mar; 6(1):53-64. PubMed ID: 15703912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of the Christo Inventory for Substance-misuse Services (CISS): a simple outcome evaluation tool.
    Christo G; Spurrell S; Alcorn R
    Drug Alcohol Depend; 2000 May; 59(2):189-97. PubMed ID: 10891633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transferring clients from intensive case management: impact on client functioning.
    Salyers MP; Masterton TW; Fekete DM; Picone JJ; Bond GR
    Am J Orthopsychiatry; 1998 Apr; 68(2):233-45. PubMed ID: 9589761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alcohol and drug abuse treatment: perceived effectiveness of inpatient combined treatment programs.
    Cole SG; Cole EA
    Am J Drug Alcohol Abuse; 1979; 6(1):109-23. PubMed ID: 507018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between time spent in treatment and client outcomes from therapeutic communities.
    Condelli WS; Hubbard RL
    J Subst Abuse Treat; 1994; 11(1):25-33. PubMed ID: 8201630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. American counselors' acceptance of non-abstinence outcome goals for clients diagnosed with co-occurring substance use and other psychiatric disorders.
    Davis AK; Rosenberg H; Rosansky JA
    J Subst Abuse Treat; 2017 Nov; 82():29-33. PubMed ID: 29021112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relation of premorbid cognitive abilities to substance users' problems at treatment intake and improvements with substance abuse treatment and case management.
    Block RI; Bates ME; Hall JA
    Am J Drug Alcohol Abuse; 2003 Aug; 29(3):515-38. PubMed ID: 14510038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Why has it proved so difficult to match drug abuse patients to appropriate treatment?
    Ball JC
    Addiction; 1994 Mar; 89(3):263-5. PubMed ID: 8173492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluating changes in symptoms and functioning of dually diagnosed clients in specialized treatment.
    Jerrell JM; Ridgely MS
    Psychiatr Serv; 1995 Mar; 46(3):233-8. PubMed ID: 7796208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of substance abuse treatment outcomes in Tennessee.
    Kedia S; Williams C
    J Drug Educ; 2003; 33(1):25-47. PubMed ID: 12773023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cultural Competence in the Treatment of Addictions: Theory, Practice and Evidence.
    Gainsbury SM
    Clin Psychol Psychother; 2017 Jul; 24(4):987-1001. PubMed ID: 27976434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changing provider practices, program environment, and improving outcomes by transporting multidimensional family therapy to an adolescent drug treatment setting.
    Liddle HA; Rowe CL; Gonzalez A; Henderson CE; Dakof GA; Greenbaum PE
    Am J Addict; 2006; 15 Suppl 1():102-12. PubMed ID: 17182425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.